VP30 vanguard: pioneering an in-silico multi-epitope vaccine against Marburg virus

Puntos clave

• The multi-epitope vaccine demonstrates promising potential for inducing immunity against Marburg virus.
• Key evidence indicates that the in-silico approach effectively maps critical epitopes, enhancing vaccine design.
• Assessment uses advanced computational techniques for epitope prediction, improving specificity and efficacy.
• This method may enable future vaccine development through improved design strategies, although further validation is needed.